Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > SC 23G/A Filing

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Feb 09, 2024 1:37pm

96 Views

Post# 35872733

RE:RE:RE:RE:RE:SC 23G/A Filing

The latest filing seems to indiacte they sold 100k shares... They only who know why is them I guess. We know nothing. When was the last time they updated the corporate presentation. When was the last time an analyst put out something on Thera. BTW half of them are MIA and still listed on their website. When was the last time Mr Marketing took the time to inforn their shareholders apart from their select group.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China